Cornell University

Get the latest news on Cornell Technologies, CTL Events, and startups based on licensed Cornell technologies by following CTL on Twitter @Cornell_CTL.

2014 Technology News


January | February | March | April | May | June | July | August | September | October | November | December


January

Cornell Startup, Metabolon, Inc., Closes $15 Million Series E Financing

January 3, 2014

Metabolon, a metabolemics-based diagnostic tests and research services company, has received $15 million in Series E  Financing to support the launch by partner Bostwick Laboratories’ Prostarix™ test and for the continued development of Metabolon’s Quantose™ IGT oral glucose tolerance test and its test for the recurrence of bladder cancer. 

Nanoparticles from Cornell May Stop Cancer from Spreading

January 6, 2014

Researchers at Cornell have designed nanoparticles that stay in the bloodstream and kill migrating cancer cells on contact.

Cornell Startup, Empire Robotics, Inc., Introduces the VERSABALL® Gripper

January 7, 2014

Empire Robotics, developers of highly adaptive universal robot grippers and automation components, launches the jamming-based VERSABALL®, a robotic gripper designed to pick up a wide range of objects of different shapes and sizes up to 20 pounds, based on technology jointly owned by Cornell and the University of Chicago.

Watch More Videos from Empire Robotics.

Cornell Startup, Empire Robotics, Now Selling Industrial Grippers to Manufacturing and Industrial Automation Companies

January 8, 2014

Empire Robotics, the Cornell University spinout company that has been working to commercialize the technology (jointly owned by Cornell and the University of Chicago) for the last year, announced that it is taking orders for the limited first release of its VERSABALL grippers scheduled to ship later this month. 

Cornell Inventor, Noah Snavely, Wins Presidential Early Career Award for Scientists and Engineers (PECASE)

January 8, 2014

Noah Snavely, assistant professor of computer science, is among the 102 winners of the Presidential Early Career Awards for Scientists and Engineers (PECASE), the highest honor bestowed by the U.S. government on early career scientists and engineers, for his work on new computational tools for extracting information from the hundreds of millions of photos shared online every day. 

Versaball, from Cornell Startup Empire Robotics, May Offer a Prosthetic Alternative

January 14, 2014

Empire Robotics’ new Versaball gripper may provide a lower-cost alternative to more realistic “bionic” prosthetic hands for performing manual labor tasks without extensive software or intricate wiring.

Cornell Lab of Ornithology Releases 'Merlin' - A Free iPhone App for Bird Identification

January 14, 2014

The Cornell Lab of Ornithology has released a free iPhone app to help people identify 285 bird species in North America based on a brief questionnaire, customized to your location and time of year. 

Cornell Startup, Alcyone Lifesciences, Inc., Closes $4 Million Series B Financing

January 15, 2014

Alcyone Lifesciences, a medical device company developing products for the treatment of difficult neuropathological conditions, closed a Series B preferred financing of $4 million to support further development of Alcyone’s platform technology for delivery of therapy to the brain. 

Cornell Collaborates with Area Colleges to Launch the Downtown Ithaca Incubator

January 16, 2014

Billed as a hub for economic activity throughout Ithaca and Tompkins County, the new Downtown Ithaca Incubator promises to channel rising entrepreneurs into the region to work, grow and thrive.

Jamming Gripper from Cornell Startup, Empire Robotics, Embodies the Latest in Robotic Theory

January 23, 2014

Roboticist John Amend has developed a new gripper that challenges the conventional design pattern but trends are aligning to make 2014 the year of the beanbag ‘bot.

New Saliva-Based Diabetes Test from Researchers at Weill Cornell Medical College in Qatar

January 26, 2014

Researchers at WCMC-Q have discovered a quick, non-invasive screening test for diabetes that does not involve either blood or urine analyses and will help expedite early diagnosis of the disease.

Weill Cornell Researchers Find Potential Trigger for Multiple Sclerosis

January 28, 2014

Researchers from Weill Cornell Medical College have found that multiple sclerosis may be triggered by a toxin produced by common foodborne bacteria.

Enzyme Discovered at Weill Cornell Suggests New Way to Target the Spread of Cancer

January 30, 2014

Researchers at WCMC have identified an important pathway responsible for the development of cancer and its spread, which may offer new opportunities to prevent metastasis. 

Cornell Team Produces First-Ever 3D-Printed Consumer Electronic

January 31, 2014

Cornell researchers have produced a working 3D printed loudspeaker - seamlessly integrating the plastic, conductive and magnetic parts – that is ready for use almost as soon as it comes out of the printer.

Cornell Inventor Receives Pioneer Award from Human Gene Therapy

January 31, 2014

Cornell researcher, Ronald Crystal, has received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary An Liebert, Inc., publishers, in recognition of his seminal work on adenoviral vectors.

February

Cornell Startup, Pacific Biosciences of California, Inc., Releases Dataset for de novo Human Genome Assembly

February 10, 2014

Pacific Biosciences, provider of the PacBio(R) RS II DNA Sequencing System, released a long-read dataset for generating the first de novo human genome assembly from PacBio-only sequence reads.

New Finding from Cornell Could Improve Male Fertility and Contraceptives

February 10, 2014

A new study headed up by Cornell scientists has found that a component of the sperm membrane tightly controls a crucial step in fertilization, making it a prime target for efforts to either assist fertilization or prevent it.

Cornell Startup, GenVec, Inc., Achieves Milestone in Hearing and Balance Collaboration

February 13, 2014

GenVec, a biopharmaceutical company working to leverage proprietary gene-delivery technologies, has achieved the third milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders.

New Trial Confirms MetaSite Breast From Cornell Startup, MetaStat, Inc., Can Predict Breast Cancer Metastasis

February 18, 2014

MetaStat, a life science company focused on developing and commercializing clinical diagnostic tests and therapeutics, completed a trial of its MetaSite Breast test that confirmed the test’s ability to accurately predict whether breast cancer would metastasize. 

Sun Powers Complex Cancer Test Developed at Cornell for Remote Regions

February 20, 2014

Cornell and WCMC researchers have remodeled an energy-intensive medical test to create a quick diagnostic assay for remote regions of the world by harnessing the sun’s power and employing a smartphone application.

Cornell Startup, Metabolon, Inc., Partners With Mexican Biotech Company, Patia Biopharma

February 24, 2014

Metabolon, developers of a biochemical biomarker discovery and profiling platform, have entered into an agreement to provide their Quantose IR™ technology for use in two large-scale studies focused on reversing type 2 diabetes trends in teens and at-risk groups in Mexico.

Cornell Scientists Use Metal Nanoparticles to Drive Polymer Process to Unprecedented Level of Precision

February 26, 2014

Cornell scientists have developed processes for using polymers to self-assemble inorganic nanoparticles into porous 3D cubic networks that could revolutionize electronics, energy and more. 

Cornell Startup, ZetrOZ, Inc., Introduces the sam® Wearable Therapeutic Ultrasound Device

February 26, 2014

ZetrOZ, a medical device company that develops miniaturization technology to deliver the spectrum of ultrasound more efficiently, more economically, and more compactly, has been cleared by the FDA to market their new pain management device, sam®, a wearable, long-duration, ultrasonic diathermy device for use in applying deep therapeutic treatment. 

Cornell Startup, Empire Robotics, Inc., Wins 2014 AUTM Business Plan Competition

February 28, 2014

Empire Robics, developers of highly adaptive universal robot grippers and automation components, won the Association of University Technology Managers (AUTM) business plan competition’s $10,000 grand prize. 

March

Cornell Startup, Metabolon, Inc., Entered Into Collaboration Agreement with Human Longevity, Inc.

March 5, 2014

Metabolon, a biomedical profiling services company, has entered into an agreement with Human Longevity, Inc. (HLI) to provide metabolomic profiling to assist in HLI’s mission to tackle diseases of aging.

Newly Engineered Molecules From Cornell Mark Proteins for Destruction

March 5, 2014

Let by Matthew DeLisa, chemical engineers at Cornell have developed a new type of antibody, called a “ubiquibody,” to tag specific proteins inside a cell for destruction, paving the way for new drug therapies and research tools.

Urine Test from WCMC Detects Common Causes of Post-Transplant Kidney Dysfunction

March 6, 2014

A new non-invasive urine test developed at Weill Cornell Medical College can distinguish among different causes of acute kidney dysfunction after transplantation. The test may allow patients to avoid invasive kidney biopsies when their transplanted organ is not functioning properly.

Cornell Startup, Widetronix, Inc., Receives $250,000 to Enhance Betavoltaic Platform

March 7, 2014

Widetronix, makers of millimeter-scale semiconductor chips that convert emitted electrons into electric power, and Cornell University have been awarded $250K each from the New York State Energy Research and Development Authority (NYSERDA) and New York Battery and Energy Storage Technology (NY-BEST) to enhance the power density of their betavoltaic platform.

Bird Identification App from Cornell Arrives Just in Time for Spring

March 10, 2014

A new smartphone app from the Cornell Lab of Ornithology is designed to help people who have never gone bird watching quickly and easily identify a bird by answering a few questions.

Cornell Named a Tax-Free Zone Under Start-Up NY

March 13, 2014

Cornell is one of eight colleges approved to become tax-free zones under Gov. Andrew Cuomo’s Start-Up NY initiative in an effort to spur business and job creation.

Cornell Startup, GenVec, Inc., Announces $9 Million Stock Offering

March 13, 2014

GenVec, a biopharmaceutical company developing gene-delivery technologies for the prevention and treatment of significant health concerns, announced an offering of $9 Million of shares of its common stock to selected institutional investors.

Cornell Startup, HμREL® Corporation, Introduces the HμREL® 4-Species Hepatic Cell-Based Assay System

March 20, 2014

Hurel, developers of bioanalytic devices used in pharmaceutical development and industrial and consumer product safety testing, announced the introduction of the HµREL® 4-Species Hepatic Cell-Based Assay System – high-functioning, stable, long-enduring primary hepatocyte co-culture plates that enable experimentation in domains not previously susceptible to in vitro methods. 

New Mouse Model from Weill Cornell Medical College Suggests Drug Targets for Anemia of Inflammation

March 25, 2014

A new animal model developed at WCMC may help investigators develop therapies for anemia of inflammation, a common condition that affects many critically ill patients in intensive care, as well as those with chronic ailments like Crohn’s disease and osteoarthritis.

Cornell Startup, Pacific Biosciences of California, Inc., Releases Software Upgrade for SMRT DNA Sequencing Platform

March 31, 2014

PacBio, developers of products that enable targeted sequencing to more comprehensively characterize genetic variations, released a software upgrade for its Single Molecule, Real-Time (SMRT) DNA Sequencing platform to support full-length transcript sequencing and human leukocyte antigen (HLA) haplotype phasing. 

April

ADC, Inc. Introduces High-Pressure Cryocooler Developed at Cornell

April 2, 2014

ADC, an engineering and scientific consulting firm that provides devices, integrated systems and high-precision components and instruments to commercial, academic, and government agencies worldwide, introduced the HPC-201, a high-pressure cryocooler that prepares proteins for X-ray crystallography. 

Cornell Startup, Axium Nanofibers LLC, to Co-Sponsor Cornell Research Into Energy Storage Devices

April 2, 2014

Axium Nanofibers, a material science company commercializing a novel class of nanomaterials for a broad range of applications including energy storage, has partnered with AZ Electronic Materials, producers of high-purity specialty chemical materials used in the manufacturing of semiconductors, flat panel displays, and LEDs, to co-sponsor research at Cornell with the goal of developing nanomaterials into commercial products for the energy storage market in the next 18-24 months. 

NIAGEN™, Based on Licensed Cornell Technology, Is the Featured Ingredient in NiaCel™, a New Product That Supports Healthy Aging

April 2, 2014

Thorne Research, manufacturer of pure, highly absorbable nutritional supplements, launched NiaCel™, a supplement that supports endurance, energy, and healthy aging, featuring the ingredient NIAGEN™, which is based on Cornell technology licensed by ChromaDex Corp.

Cornell Startup, Metabolon, Inc., Launches Fourth Generation DiscoveryHD4™ Metabolomics Platform

April 3, 2014

Metabolon, pioneers in the emerging field of metabolomics-driven biomarker discovery, announced the launch of DiscoveryHD4™, the company’s fourth-generation metabolomics platform designed to empower the company’s TrueVision™, mVision™, and mView™ research and biomarker discovery offerings as well as its diagnostic product development pipeline. 

Weill Cornell Researchers Discover A Possible Cure for Cardiac Disease Associated with Friedreich's Ataxia

April 7, 2014

WCMC researchers, along with an international team, discovered a way to cure cardiac disease in mice with a fatal muscle disorder that usually strikes teenagers. Two-thirds of patients with the disease, Friedreich's ataxia, die of failing hearts in their early 30s.

Weill Cornell Scientists Find Possible Ways to Switch Circuit Back On In A Severely Injured Brain

April 17, 2014

A study led by WCMC investigators demonstrates a common dysfunction that appears to underlie a majority of severe brain injuries and provides a road map to assess the potential that brain injury may be reversed.

New Alfalfa Variety from Cornell Resists Ravenous Local Pest

April 23, 2014

Cornell plant breeders have released a new alfalfa variety – Seedway 9558 SBR – with some resistance against the alfalfa snout beetle, which has infested alfalfa fields in northern New York State and Canada and has been spreading.

WCMC Scientist, As Part of An International Team, Discovers A New Point of Attack on HIV for Vaccine Development

April 25, 2014

John Moore of Weill Cornell Medical College is part of an international team of scientists led by The Scripps Research Institute (TSRI), working with the International AIDS Vaccine Initiative (IAVI), that has discovered a new vulnerable site on the HIV virus that can be attacked by human antibodies.

Cornell Startup, Metabolon, Inc., Considering IPO

April 28, 2014

Metabolon, a medical technology firm that tests how diseases and drugs affect the body, is working on an initial public offering that could launch in the next couple of months.  

Cornell Startup, Metabolon, Inc., Debuts MetaboLync™ Client Portal

April 29, 2014

Metabolon, a company focused on metabolomics-driven biomarker discovery, announced the impending launch of a cloud-based solution for sharing and exploring metabolomics data to “empower users to more effectively visualize and navigate thru their own results interactively.”

Cornell Startup, Orthogonal, Inc., Is Exploring Brighter, High-Res OLED Microdisplay

April 29, 2014

Orthogonal, developers of “organic” or carbon-based electronics, is collaborating with Fraunhoffer COMEDD to explore a novel approach for Orthogonal Photolithography, which allows direct patterning of organic material on CMOS-backplanes, making bright high-res micro-displays possible.  

Sequencing Platform from Cornell Startup, Pacific Biosciences of California, Inc., Selected by HistoGenetics for Human Leukocyte Antigen Typing

April 29, 2014

Pacific Biosciences, developers of the Single Molecule Real Time (SMRT™) platform,  announced that HistoGenetics, a Human Leukocyte Antigen (HLA) typing company, has selected the PacBio RS II for its unique ability to sequence full-length HLA genes and to provide fully phased HLA alleles.

Optical Traps On A Chip From Cornell Can Manipulate Many Molecules At Once

April 30, 2014

Optical trapping, a technique which uses light to suspend and manipulate molecules like DNA and proteins, is traditionally a delicate process. Cornell physicists have shrunk the technology onto a single chip that can potentially trap hundreds of molecules at once, reducing month-long experiments to days. 

May

Cornell Scientists Report Using Defatted Biomass May Replace Some Corn and Soybean Used for Animal Feed

May 1, 2014

Defatted microalgal biomass may be used as a "new feed ingredient in offsetting the biofuel production cost, reducing the dependence on staple crops, decreasing greenhouse gas production of animal  agriculture, and developing health value-added animal products."  

Cornell Startup, Achronix Semiconductor Corporation Announces PCI-SIG® Compliance for Speedster22i FPGAs

May 7, 2014

Achronix announced that its 22nm Speedster22i devices have achieved PCI-SIG® compliance with the hardened PCI Express® (PCle®) 3.0 specification for x8 lanes, which frees up a substantial portion of the programmable logic fabric, increasing the effective capacity and reducing overall power consumption.  

Weill Cornell Scientists Develop Man-Made Tissue With Built-In Blood Vessels

May 7, 2014

Tissue engineers at WCMC have created replacement body tissue with built-in blood vessels, an advance that overcomes the problem of getting an immediate and adequate blood supply to human-engineered tissues as soon as they are transplanted into the patient.

WCMC Neuroscientists May Be Able to Reverse Schizophrenia and Other Psychiatric Disorders

May 7, 2014

A team of neuroscientists has reversed psychosis-like features in mice, raising hope that scientists might be able to do the same for humans.

New York Governor Andrew Cuomo Announces Winners of PowerBridgeNY Contest, Including Two From Cornell

May 12, 2014

Gov. Cuomo announced the first round of awards from PowerBridgeNY, a contest that aims to drive the development of clean energy products. Among the winners are two projects from Cornell, including a team researching longer battery life and faster recharge time for new lithium oxide batteries, and a team developing new materials to absorb carbon dioxide emissions. 

Cornell Startup, Metabolon, Inc., Enters Into Collaboration with GlaxoSmithKline

May 13, 2014

Metabolon, a diagnostics and research services company offering metabolomics platforms, has entered into an agreement with GSK to provide metabolomics profiling services and to collaborate on other research projects leveraging Metabolon’s DiscoveryHD4™platform.  

Anthony Nolan Organization To Use Cornell Startup Pacific Biosciences' DNA Sequencing Technology For Its Stem Cell Registry

May 13, 2014

The Anthony Nolan organization, the UK blood cancer charity, announced it will invest in two PacBio RS II systems to unambiguously phase HLA alleles for research in bone marrow and blood stem cell transplantation.  

A Synthetic Biology Approach from Cornell To Improve Photosynthesis

May 14, 2014

A joint effort from Cornell and Rothamsted Research scientists marks important progress toward the goal of making plants more efficient at fixing carbon dioxide from the air into molecules that can be used by the plant for growth.  

Cornell Startup, MiTeGen LLC, Announces Agreements to Develop Microrobots

May 14, 2014

MiTeGen, provider of consumables for X-ray diffraction, crystallography and protein crystallization, announced that it has signed agreements with MagnebotiX, NatX-ray SAS, and NatX-ray LLC for the development and distribution of RodBots - rod-shaped, magnetically responsive microrobots for crystallization and crystal handling. 

New High-Performance Lithium-ion Component From Cornell Makes Batteries Safer

May 15, 2014

Cornell scientists have designed a new lithium battery component that is far less likely to catch fire and promises effective performance, paving the way for safer smartphones and tablets.

Cornell Startup, MetaStat, Inc., Featured in Nature

May 16, 2014

MetaStat, a life science company focused on understanding and treating systemic metastasis, was featured in an article titled “Cancer Caught in the Act,” highlighting the increased use of intravital imaging to monitor tumor cells as well as the growth, spread, and treatment of cancer in living animal cells.

Tests from Weill Cornell Medical College Could Lead to Earlier, Easier Cancer Diagnosis and Targeted Treatment

May 21, 2014

Double-stranded DNA fragments in tumor exosomes may enable physicians to use a blood test to find cancers earlier, as well as monitor patients’ response to treatments.

Cornell Startup, MiTeGen LLC, Awarded $998K NIH Phase II SBIR Grant to Develop Hyperquenching Devices

May 24, 2014

MiTeGen, providers of consumables for X-ray diffraction, crystallography, and protein crystallization, has been awarded a Phase II SBIR (Small Business Innovation Research program) grant for the development of a rapid crystal cooling device (“hyperquencher”) for cryocrystallography and other sciences requiring safe, controlled, high-speed cooling of samples.  

BioTime, Inc. Subsidiary, OncoCyte Corporation, Enters License Agreement with Cornell

May 27, 2014

OncoCyte, developers of products for the diagnosis and treatment of cancer in order to improve the quality and length of life for patients, has entered into a license agreement with Cornell to accelerate lung cancer diagnostic product development.

Findings from Cornell Holds Promise for Developing Iron-rich, Cadmium-free Crops

May 29, 2014

A new study describes the role of a transporter protein that regulates how much iron from the soil is needed by the plant and allows the plant to partition cadmium away from the edible portions.

Cornell Startup, Novomer, Inc., Launches Converge® Polyols Products

May 29, 2014

Novomer, a sustainable materials company developing a family of high-performance polymers from renewable feedstocks such as carbon dioxide, has announced Converge® polypropylene carbonate (PPC) polyols for use in polypropylene formulations such as adhesives, coatings, sealants, elastomers, and rigid and flexible foams.

June

Cornell Startup, MetaStat, Inc., Announces Results of MetaSite Breast Test Study

June 4, 2014

MetaStat, a life science company that develops diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis, announced the publication of results from a study of its MetaSite Breast test that validate the test’s ability to show a strong and statistically significant association with the risk of metastasis for the most common type of breast cancer. 

Tags: Weill Cornell Medical College, Cornell Startups, Life Sciences News

Cornell Startup, Metabolon, Inc., Announces Quantose IR™ Prediabetes Test Is Now Available In Mexico

June 4, 2014

Metabolon, a commercial-stage metabolomics company in the field of biochemical pathway analysis for biomarker discovery and development of innovative, cost-effective diagnostic tests, announced that its Quantose IR™ prediabetes test is now available to physicians in Mexico through its commercial partner PATIA Biopharma.  

Tags: Weill Cornell Medical College, Life Sciences News, Products Based on Licensed Cornell Technology

VERSABALL® From Cornell Startup, Empire Robotics, Inc., Wins First Prize at Service Robotics Awards

June 5, 2014

VERSABALL®, a flexible method of gripping and moving objects from Empire Robotics, won first place at the Service Robotics Awards Ceremony held at AUTOMATICA 2014 in Munich, Germany.

Tags: College of Engineering, Cornell Startups, Physical Sciences News, Products Based on Licensed Cornell Technology

Ithaca Firm and Cornell Team Up in 3D Printing Enterprise in First Wave of StartUP NY

June 5, 2014

Incodema3D, an offshoot of a rapid prototyping firm looking to expand into additive manufacturing to create precision metal and plastic components, will be the first StartUp NY business in Tompkins County.

Tags: College of Engineering, Physical Sciences News, Cornell News, Partnerships

Weill Cornell Researchers Have Discovered A Drug Therapy That May Prevent Tongue Cancer

June 11, 2014

A drug combination discovered at Weill Cornell Medical College shows promise in the preventative treatment of individuals at risk for developing tongue cancer.

Tags: Weill Cornell Medical College, Life Sciences News

GenDx to Offer a Version of NGSgo® Reagent Line for Cornell Startup, Pacific Biosciences of California, Inc.'s Gene Sequencing System

June 19, 2014

GenDX, a Dutch molecular diagnostics company that develops In Vitro Diagnostic (IVD) tests and services, and Pacific Biosciences, provider of the PacBio® RS II DNA sequencing system, announced a co-marketing agreement to offer a new reagent kit for full-length Human Leukocyte Antigen (HLA) gene sequencing.  

Tags: College of Engineering, Weill Cornell Medical College, Cornell Startups, Life Sciences News, Partnerships

Cornell Startup, ZetrOZ, Inc., Raises $2 Million for Sam®, Its Wearable Ultrasound Device

June 26, 2014

ZetrOZ, a medical device company developing ultrasound therapies, has raised more than $2 million for Sam®, an FDA-cleared, iPod-sized, wearable device designed to relieve pain and improve circulation.

Tags: College of Engineering, Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology, Financing

July

Cornell Startup, GeneWeave Biosciences Inc., Attracts $12 Million to Provide Diagnostic Solutions for Multi-Drug-Resistant Organisms

July 2, 2014

GeneWeave, an in vitro diagnostics company that advances clinical microbiology with diagnostic solutions to prevent drug-resistant infections, announced the completion of its $12 million Series B financing to support clinical studies and commercialization of the company’s sample-in/susceptibility-out platform technology.

Tags: College of Agiculture & Life Sciences, Cornell Startups, Life Sciences News, Financing

Cornell Startup, MetaStat, Inc., Closes $5.7 Million Equity Financing

July 2, 2014

MetaStat, a life sciences company focused on understanding and treating systemic metastasis, announced that it has entered into a securities purchase agreement in a private placement totaling $5.7 million, which will enable the company to accelerate the development and commercialization of its cancer diagnostic platform.

Tags: Weill Cornell Medical College, Cornell Startups, Life Sciences News, Financing

Researchers from WCMC Reprogram Cells for Treating Blood Disorders

July 8, 2014

Weill Cornell Medical College researchers have directly reprogrammed vascular cells into long-lasting blood cells that resemble bone marrow stem cells capable of forming the various components of blood necessary for life and could eventually offer millions of patients with blood disorders curative therapies derived from their own cells.

Tags: Weill Cornell Medical College, Life Sciences News

ChromaDex Initiates Human Clinical Trial of NIAGEN™, Based On Licensed Cornell Technology

July 16, 2014

ChromaDex Corp., a natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announce the initiation of the first human clinical study for its patented ingredient NIAGEN™, a commercially available form of nicotinamide riboside (NR), based on licensed Cornell technology.

Tags: College of Agiculture & Life Sciences, Life Sciences News, Products Based on Licensed Cornell Technology

Cornell Startup, MetaStat, Inc., to Transfer Therapeutic Business to ASET Therapeutics

July 17, 2014

MetaStat, a life science company focused on understanding and treating systemic metastasis, announced that it entered into a Memorandum of Understanding (MOU) to transfer therapeutic assets (including licenses, personnel, and laboratory space) to newly formed ASET Therapeutics, leaving MetaStat to focus on being “a pure play diagnostic company with a platform of cancer diagnostics and companion biomarkers for multiple cancer indications.”

Tags: Weill Cornell Medical College, Cornell Startups, Life Sciences News, Partnerships

Cornell Startup, Novomer, Inc., Names Quimidroga S.A. an Authorized Distributor in Europe

July 23, 2014

Novomer, producers of low-cost, high performance sustainable polymers and other chemicals, has named Quimidroga as an authorized distributor of its Converge polypropylene carbonate polyols in Spain, Portugal, and Turkey for use in polyurethane formulations targeted at adhesive, coatings, sealants, elastomers and rigid and flexible foams.  

Tags: College of Engineering, Cornell Startups, Physical Sciences News, Partnerships

Topological Spintronics from Cornell May Lead to More Efficient Computer Memory

July 24, 2014

Cornell physicists have discovered a new material combination, known as “topological insulators,” that can be 10 times more efficient for controlling magnetic memory or logic than any other combination of materials measured to date.

Tags: College of Engineering, Physical Sciences News

August

Cornell Scientists Have Discovered A New Player in Lipid Metabolism

August 4, 2014

Researchers have discovered a novel function of a gene involved in the clearance of misfolded proteins in fat cells, SEL1L, showing that it also serves as a regulator of lipid metabolism.

Tags: College of Agiculture & Life Sciences, Life Sciences News

Goose Watch Winery First in the Nation to Release 'Aromella' Wine

August 5, 2014

Goose Watch announces the release of 2013 Aromella, a varietal wine made from grapes developed at Cornell University. 2013 Aromella is an aromatic semi-dry white wine with distinctive characteristics that boasts some of the favored flavors from the Muscat grape used in the trending Moscatos such as peaches and tropical fruits, but with less sweetness.

Tags: College of Agiculture & Life Sciences, New York State Agricultural Experiment Station - Geneva, Life Sciences News, Products Based on Licensed Cornell Technology

Brush From Cornell Startup, Immunovent, LLC, May Replace Allergy Pricks

August 5, 2014

Immunovent has developed a less painful and possibly more accurate allergy test using a brush to collect cells from inside the cheek and nose and tests them with its Local Antibody Mucosal Brush Diagnostic (LAMB-Dx), a method which may replace uncomfortable and often unreliable prick tests.

Tags: Weill Cornell Medical College, Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

Relmada Therapeutics, Licensee of Cornell's D-methadone, Completes Company Name Change, Announces New Ticker

August 6, 2014

Relmada, a clinical-stage company developing novel therapies for the treatment of chronic pain including D-methadone from Cornell, has completed a name change from Camp Nine, Inc. to Relmada Therapeutics, Inc. and has been assigned a new trading symbol, RLMD.

Tags: Weill Cornell Medical College, Life Sciences News, Products Based on Licensed Cornell Technology, Partnerships

Cornell Tech's Rajit Manohar Helps Design IBM 'Brain Chip'

August 13, 2014

Manohar, associate dean for academic affairs at Cornell Tech and professor of electrical and computer engineering, pioneered the design methodology for a new IBM computer chip inspired by the human brain.

Tags: Cornell NYC Tech, Physical Sciences News, Partnerships

Cornell Grapes in Two Winning Varietals at 2014 New York Wine & Food Classic

August 13, 2014

Lucas Vineyards’ 2013 Cayuga White took home “Best Cayuga” and 2013 Traminette from Thirsty Owl Wine Company took home “Best Traminette” at the 2014 New York Wine & Food Classic. Both ‘Cayuga White’ and ‘Traminette’ are wine grapes that were developed by Cornell’s grape breeding program. 

Tags: College of Agiculture & Life Sciences, New York State Agricultural Experiment Station - Geneva, Life Sciences News, Products Based on Licensed Cornell Technology

Cornell Chemical Engineers Achieve Battery Breakthrough

August 14, 2014

In the race for safer, longer-lasting batteries to power the world’s automobiles, cell phones, computers, and autonomous robots, Cornell engineers have discovered a method to potentially extend the daily cycle life of a rechargeable lithium battery by up to a factor of 10.

Tags: College of Human Ecology, Physical Sciences News

Adapt-N from Cornell Startup, Agronomic Technology Corporation, Reduces Emissions and Saves Crops

August 20, 2014

Adapt-N, a software program that assists farmers in determining how and when to apply nitrogen fertilizer to their fields, could help reduce greenhouse gas emissions, protect crops, and save farmers money.

Tags: College of Agiculture & Life Sciences, Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

License Granted to Cornell Startup, Angiocrine Bioscience, Inc., May Lead to New Therapies for Blood Disorders

August 21, 2014

Angiocrine Bioscience, a biotech company focused on applying vascular biology to new therapeutic applications and developer of the VeraVec™ technology platform, has licensed the rights to a new technology from Weill Cornell Medical College that converts a patient’s own endothelial cells directly into blood stem cells capable of treating a variety of diseases with fewer risks than using blood from a donor.

Tags: Weill Cornell Medical College, Cornell Startups, Life Sciences News

Cornell Startup, Empire Robotics, Inc., to Start Shipping Versaball Gripper in September

August 21, 2014

Empire Robotics plans to start shipping the Versaball Gripper, a soft attachment for steel robot arms that contours to the shape of the object it is trying to pick up and can clench without crushing, in September.

Tags: College of Engineering, Cornell Startups, Physical Sciences News, Products Based on Licensed Cornell Technology

September

Cornell Startup, BinOptics Corporation, Unveils New Lasers for Data Center Applications

September 10, 2014

BinOptics, developers of semiconductor lasers for the Telecom and Datacom industries, announced the availability of 25G lasers at four wavelengths, allowing 100G solutions for Data Centers that will provide an increase in data transfer with lower power consumption per bit of transferred data.

Tags: College of Engineering, Cornell Startups, Physical Sciences News, Products Based on Licensed Cornell Technology

SMRT Sequencing from Cornell Startup, Pacific Biosciences of California, Inc., Effectively Tracks Infectious Disease Pathogens

September 17, 2014

Pacific Biosciences, creators of the PacBio RS II DNA Sequencing System, announced the publication of several papers highlighting the advantages of Single Molecule, Real-Time (SMRT) Sequencing over short-read sequencing technologies for infectious disease applications.

Tags: Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

Quantose™ Prediabetes Tests from Cornell Startup, Metabolon, Inc., Now Available in Europe

September 17, 2014

Metabolon, a life sciences company focused on the study of small molecules and an integral technology for understanding the function of biological systems, has partnered with Metdia Biotech, S.L. to commercialize its Quantose IR™ and Quantose IGT™ prediabetes tests in Spain, Portugal, France, Italy, the United Kingdom, Germany, Switzerland, Sweden, Norway, Denmark, Finland, the Netherlands, Belgium, and Austria.

Tags: Weill Cornell Medical College, Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

Cornell Scientists Engineer Plants for More Efficient Photosynthesis

September 17, 2014

A genetically engineered tobacco plant, developed with two genes from blue-green algae, holds promise for improving yields of many food crops.

Tags: College of Agiculture & Life Sciences, Life Sciences News

Cornell Startup, Pacific Biosciences of California, Inc., Announces Use of SMRT Sequencing for de Novo Asian Reference Genomes

September 23, 2014

Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, announced that Macrogen, providers of genome sequencing services, has selected the PacBio Single Molecule, Real-Time (SMRT) Sequencing platform to create high-quality de novo human genome references for the Asian population. The current human genome reference was predominantly derived from a Caucasian individual and its utility is limited for researchers investigating certain diseases that differ genetically between ethnicities.

Tags: Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

Johnston Associates Invests in Cornell Startup, Hurel Corporation, in Series A-3 Preferred Stock Financing

September 24, 2014

Hurel, provider of in vitro liver models and microfluidic assay platforms that improve the predictive reliability of pre-clinical drug development, announced that Johnston Assoicates, Inc. has become a participating investor in the company’s Series A-3 Preferred Stock financing.

Tags: Cornell Startups, Life Sciences News, Financing

Meet Aromella, the Newest Finger Lakes Wine Made from Cornell Grapes

September 30, 2014

Aromella is a limited release varietal white wine that is semi-dry white and marked by peach and tropical fruit aromas, similar to the trendy Italian wine, Moscato.

Tags: College of Agiculture & Life Sciences, New York State Agricultural Experiment Station - Geneva, Life Sciences News, Products Based on Licensed Cornell Technology

October

NIAGEN™ from Cornell licensee, ChromaDex Corp, Is the Featured Ingredient in a New Anti-Aging Supplement from Life Extension

October 1, 2014

Life Extension announced the launch of NAD+ Cell Regenerator™, a nutritional supplement that boosts vitality and supports healthy aging, featuring the ingredient NIAGEN™ from ChromaDex, a natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. NIAGEN™ is the commercially available brand of Nicotinamide Riboside (NR), developed at Cornell.

Tags: Weill Cornell Medical College, Life Sciences News, Products Based on Licensed Cornell Technology

Human Longevity, Inc. Is Now Using Cornell Startup, Pacific Biosciences of California, Inc.'s SMRT Technology

October 6, 2014

Human Longevity, Inc. has added Pacific Bioscience’s Single Molecule, Real-Time (SMRT®) Sequencing technology to their repertoire of DNA sequencing technologies to compile a comprehensive human genotype, microbiome, and phenotype database.

Tags: Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology, Partnerships

New Technology Platform From Cornell Startup, Lumidyne Technologies, LLC, May Help Prevent HIV Infection

October 8, 2014

Researchers at Weill Cornell Medical College have developed technologies that allow investigators to watch HIV proteins on the virus’ surface, which may contribute to how it infects human immune cells.

Tags: Weill Cornell Medical College, Cornell Startups, Life Sciences News

Cornell Startup, Agronomic Technology Corp., Receives Armory Square Ventures' First Investment

October 10, 2014

Armory Square Ventures, a new venture fund, has closed its first investment as part of a $2.2 million round of financing for Agronomic Technology Corp.

Tags: College of Agiculture & Life Sciences, Cornell Startups, Life Sciences News, Financing

Cornell Startup, Hurel Corporation, and ACEA Biosciences Announce Joint Marketing of Integrated Product Kits

October 13, 2014

Hurel, a provider of in vitro liver models that bring improved translational utility to pre-clinical drug development, and ACEA Biosciences, provider of impedance-based, label-free, real-time cell analysis instrumentation, announced that they will begin to offer their respective technologies combined together in a single, integrated cell-based assay platform with a launch planned for the first quarter of 2015.

Tags: Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

Cornell's Newest Apple Varieties, SnapDragon™ and RubyFrost®, Come to Market

October 15, 2014

Production of Cornell’s newest apple varieties is ramping up with SnapDragon coming to market in limited quantities this November and RubyFrost becoming available through several retailers in January 2015.

Tags: College of Agiculture & Life Sciences, New York State Agricultural Experiment Station - Geneva, Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

Cornell Startup, Pacific Biosciences of California, Inc., Releases New DNA Sequencing Chemistry

October 15, 2014

Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, announced the release of new chemistry and software designed to enhance read length and accuracy for the study of human and other complex genomes.

Tags: Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology

New DNA Sequencing Facility in China Is Based on Cornell Startup, Pacific Biosciences of California, Inc.'s SMRT Sequencing Platform

October 27, 2014

Pacific Biosciences announced that Suqian Lakeside Pangu Gene Company (SLPC) established a new 1,500 square meter genomics facility in Tianjin, China dedicated to using PacBio Single Molecule, Real Time (SMRT®) Sequencing as the major sequencing platform for its translational medicine research projects.

Tags: Cornell Startups, Life Sciences News, Products Based on Licensed Cornell Technology, Partnerships

November

Cornell Startup, Novomer, Inc., Launches A New Polymer That Is 50% Carbon Dioxide

November 20, 2014

Novomer, a sustainable chemistry company developing a family of high-performance, environmentally responsible polymers and chemical intermediates, announced the commercial debut of polypropylene carbonate, a sustainable, low-cost plastic that is up to 50 percent carbon dioxide.

Tags: College of Human Ecology, Cornell Startups, Physical Sciences News, Products Based on Licensed Cornell Technology

December

Weill Cornell Medical College Researchers Use a Vitamin to Potentially Prevent Noise-Induced Hearing Loss

December 3, 2014

Researchers may have found a way to prevent noise-induced hearing loss in a mouse using a simple chemical compound that is a precursor to vitamin B3. This discovery also may have implications for treating some aging-related conditions that are linked to the same protein.

Tags: Weill Cornell Medical College, Life Sciences News

Cornell Researchers Develop Carbon-Trapping "Sponges" That May Cut Greenhouse Gasses

December 15, 2014

Cornell researchers have invented a low-toxicity powder that performs as well or better than industry benchmarks for carbon capture to chemically trap carbon dioxide before it releases into the atmosphere.

Tags: College of Engineering, Physical Sciences News

WCMC Researchers Have Discovered A Link Between Prostate and Breast Cancer, Suggesting New Treatments

December 15, 2014

Prostate cancer can be driven by the same estrogen receptor responsible for the most common form of breast cancer, which suggests why the most aggressive forms of prostate cancer do not respond to traditional therapy. The new study from Weill Cornell Medical College opens up potential for new prognostic biomarkers and treatments.

Tags: Weill Cornell Medical College, Life Sciences News

Cornell Startup, Kionix, Inc., Launches Ultra-Thin Full-Functional Tri-Axis Accelerometers

December 22, 2014

Kionix, a leading MEMs manufacturer, announced a lineup of full-featured ultra-thin low-power accelerometers suited primarily for mobile, PC/tablet, and wearable applications.

Tags: Cornell Startups, Products Based on Licensed Cornell Technology

For more archived news items, click here.